ID   HepG2-hNTCP
AC   CVCL_JY40
DR   cancercelllines; CVCL_JY40
DR   Wikidata; Q54882852
RX   PubMed=24361467;
CC   Population: Caucasian.
CC   Sequence variation: Mutation; HGNC; 7989; NRAS; Simple; p.Gln61Leu (c.182A>T); ClinVar=VCV000375874; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; 11730; TERT; Simple; c.1-124C>T (c.228C>T) (C228T); Zygosity=Unspecified; Note=In promoter (from parent cell line).
CC   Transfected with: HGNC; 10905; SLC10A1.
CC   Derived from site: In situ; Liver; UBERON=UBERON_0002107.
DI   NCIt; C3728; Hepatoblastoma
DI   ORDO; Orphanet_449; Hepatoblastoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0027 ! Hep-G2
SX   Male
AG   15Y
CA   Cancer cell line
DT   Created: 22-08-17; Last updated: 05-10-23; Version: 13
//
RX   PubMed=24361467; DOI=10.1053/j.gastro.2013.12.024;
RA   Ni Y., Lempp F.A., Mehrle S., Nkongolo S., Kaufman C., Falth M.,
RA   Stindt J., Koniger C., Nassal M., Kubitz R., Sultmann H., Urban S.;
RT   "Hepatitis B and D viruses exploit sodium taurocholate co-transporting
RT   polypeptide for species-specific entry into hepatocytes.";
RL   Gastroenterology 146:1070-1083(2014).
//